Evidence map›Paper›PMID 34549484›Full record

Observational studyJournal of the peripheral nervous system : JPNS2021

Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study.

Sonja E Leonhard, Cheng Yin Tan, Annemiek A van der Eijk, Ricardo R Reisin, Suzanne C Franken, Ruth Huizinga, Samuel Arends, Manou R Batstra, Selma M Bezerra Jeronimo, Judith Drenthen and 10 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of the peripheral nervous system : JPNS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. The firstClinical case reports · 2023
    Article
  9. Nervous System Manifestations of Arboviral Infections.Current tropical medicine reports · 2022
    Review
  10. Review
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 4 countries.

Sonja E LeonhardDepartment of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-4832-6926
Cheng Yin TanDepartment of Medicine, University of Malaya Medical Center, Kuala Lumpur, Malaysia.ORCID 0000-0002-3578-3493
Annemiek A van der EijkDepartment of Viroscience, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Ricardo R ReisinDepartment of Neurology, Hospital Británico, Buenos Aires, Argentina.
Suzanne C FrankenDepartment of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Ruth HuizingaDepartment of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Samuel ArendsDepartment of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Manou R BatstraDepartment RH-MDC - Immunology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
Selma M Bezerra JeronimoInstitute of Tropical Medicine of Rio Grande do Norte, Federal University of Rio Grande do Norte, Natal, Brazil.
Judith DrenthenDepartment of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-2165-6573
Laura de KoningDepartment of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Luciana Leon CejasDepartment of Neurology, Hospital Británico, Buenos Aires, Argentina.ORCID 0000-0003-4109-3963
Cintia MarchesoniDepartment of Neurology, Hospital Británico, Buenos Aires, Argentina.
Wilson MarquesDepartment of Neurology, Hospital das Clinicas da Faculdade de Medicina, Ribeirão Preto, Brazil.
Nortina ShahrizailaDepartment of Medicine, University of Malaya Medical Center, Kuala Lumpur, Malaysia.
Dardo F CasasDepartment of Neurology, Hospital Dr Enrique Vera Barros, La Rioja, Argentina.
Andrea SoteloDepartment of Neurology, Sanatorio Adventista del Plata, Entre Rios, Argentina.
Belen TillardDepartment of Neurology, Sanatorio Los Arcos, Buenos Aires, Argentina.
Mario-Emilio DouradoDepartment of Neurology, Hospital Universitário Onofre Lopes, Natal, Brazil.
Bart C JacobsDepartment of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLHospital Británico de Buenos Aires · ARUniversity Malaya Medical Centre · MYClinics Hospital of Ribeirão Preto · BRHelios Salud · ARHospital Universitário Onofre Lopes · BRNational University of La Rioja · ARReinier de Graaf Hospital · NLUniversidad Adventista del Plata · ARUniversidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Half of the world's population is at risk of arthropod-borne virus (arbovirus) infections. Several arbovirus infections have been associated with Guillain-Barré syndrome (GBS). We investigated whether arboviruses are driving GBS beyond epidemic phases of transmission and studied the antibody response to glycolipids. The protocol of the International Guillain-Barré syndrome Outcome Study (IGOS), an observational prospective cohort study, was adapted to a case-control design. Serum samples were tested for a recent infection with Zika virus (ZIKV), dengue virus (DENV), chikungunya (CHIKV) virus, hepatitis E virus, Epstein-Barr virus (EBV), cytomegalovirus (CMV), Campylobacter jejuni, and Mycoplasma pneumoniae, and for antibodies to glycolipids. Forty-nine patients were included from Brazil (63%), Argentina (14%), and Malaysia (22%). Evidence of a recent infection was found in 27/49 (55%) patients: C jejuni (n = 15, 31%), M pneumoniae (n = 5, 10%), CHIKV (n = 2, 4%), EBV (n = 1, 2%), C jejuni and M pneumoniae (n = 2, 4%), CMV and DENV (n = 1, 2%), and C jejuni and DENV (n = 1, 2%). In 22 patients, 35 paired controls were collected. Odds ratio for recent infections did not significantly differ between cases and controls. No typical anti-ganglioside antibody binding was associated with recent arbovirus infection. We conclude that arbovirus infections occur in GBS patients outside of epidemic viral transmission, although not significantly more than in controls. Broad infection and anti-ganglioside antibody serology are important to establish the most likely pathogenic trigger in GBS patients. Larger studies are necessary to determine the association between arboviruses and GBS.

Indexed as

ArbovirusesCytomegalovirus InfectionsEpstein-Barr Virus InfectionsGuillain-Barre SyndromeZika VirusZika Virus InfectionCase-Control StudiesGangliosidesHerpesvirus 4, HumanHumansProspective StudiesGangliosidesanti-ganglioside antibodiesanti-glycolipid antibodieschikungunya virusdengue virusGuillain-Barré syndromeZika virus

Identifiers

PMID34549484
PMCPMC9291970
OpenAlexW3201554735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.